Home
Home
/
Products
Products
/
Bioactive Compounds
Bioactive Compounds
/
MAPK/ERK Pathway
MAPK/ERK Pathway
/
p38 MAPK
p38 MAPK
p38 MAPK
Products (17)
Pf-03715455
CAS No.:
1056164-52-3
3-(3-tert-butyl-6,8-difluoro-[1,2,4]triazolo[4,3-a]pyridin-7-yl)-N-cyclopropyl-5-fluoro-4-methylbenzamide
CAS No.:
1057394-06-5
VX-702
CAS No.:
745833-23-2
Falnidamol
CAS No.:
196612-93-8
PH 797804
CAS No.:
586379-66-0
Sgx-523
CAS No.:
1022150-57-7
Naporafenib
CAS No.:
1800398-38-2
Chf-6297
CAS No.:
1443242-46-3
Dilmapimod
CAS No.:
444606-18-2
5-(2,6-Dichlorophenyl)-2-((2,4-difluorophenyl)thio)-6H-pyrimido(1,6-b)pyridazin-6-one
CAS No.:
209410-46-8
Acumapimod
CAS No.:
836683-15-9
Sea5ekp5LY
CAS No.:
1590403-33-0
Pexmetinib
CAS No.:
945614-12-0
Pamapimod
CAS No.:
449811-01-2
Exarafenib
CAS No.:
2639957-39-2
Emprumapimod
CAS No.:
765914-60-1
MAP2K7 inhibitor DK2403
CAS No.:
2902651-64-1
Products
CDMO Compounds
API & Candidates
Services
CDMO & Manufacturing
Custom Synthesis
Process Development
Lab To Pilot
Commercialization
Generic APIs
CRO
Preclinical
Pharmacology & Efficacy
DMPK & Bioanalysis
Toxicology & Safety
Disease Models
Technologies
High-Potent
Chiral Synthesis
Cloud Synthesis
Fermentation
Flow Chemistry
Biocatalysis
Support
Regulatory Support
Supply Chain Solutions
About
Perspectives
Contact